Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 226,543,840 papers from all fields of science
Search
Sign In
Create Free Account
Stage 3 lower case b
Known as:
stage 3b
, stage iiib
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Stage 3B
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
The prognostic efficacy and improvements of the 7th edition Union for International Cancer Control tumor–node–metastasis classifications for Chinese patients with gastric cancer: Results based on a…
Huizi Gu
,
Dongmei Li
,
+6 authors
P. Lu
Tumour biology : the journal of the International…
2017
Corpus ID: 206612810
This study aimed to evaluate survival trends for patients with gastric cancer in northeast China in the most recent three decades…
Expand
2012
2012
Validation of the seventh edition of the American Joint Committee on cancer tumor node‐staging system in patients with colorectal carcinoma in comparison with sixth classification
Jun Seok Park
,
G. Choi
,
+4 authors
Sang Gyu Kwak
Journal of Surgical Oncology
2012
Corpus ID: 22484379
The aim of this study was to compare survival rates assessed by the seventh‐staging system with those by the sixth classification…
Expand
2007
2007
Prognostic Factors Affecting Locoregional Recurrence in Patients with Stage IIIB Noninflammatory Breast Cancer
K. Gülben
,
U. Berberoǧlu
,
A. Cengiz
,
H. Altınyollar
World Journal of Surgery
2007
Corpus ID: 13180853
BackgroundThe aim of the present study was to identify the clinicopathological factors affecting locoregional recurrence (LRR) in…
Expand
Review
2004
Review
2004
Therapeutic advances in second-line treatment of advanced non-small-cell lung cancer.
P. Bonomi
Clinical Lung Cancer
2004
Corpus ID: 27295133
A majority of patients with lung cancer present with advanced disease: approximately 30% with locally advanced disease and 45…
Expand
Review
2002
Review
2002
Gemcitabine, ifosfamide and Navelbine (GIN): a platinum-free combination in advanced non-small-cell lung cancer (NSCLC)
E. Baldini
,
A. Ardizzoni
,
T. Prochilo
,
M. Cafferata
,
L. Boni
,
C. Tibaldi
Cancer Chemotherapy and Pharmacology
2002
Corpus ID: 28166485
HeadingAbstractPurpose. To evaluate the activity and toxicity of gemcitabine, ifosfamide and Navelbine (GIN) in advanced NSCLC…
Expand
2001
2001
Induction and concurrent paclitaxel/carboplatin every 3 weeks with thoracic radiotherapy in locally advanced non-small-cell lung cancer: an interim report.
B. Movsas
,
R. Hudes
,
+8 authors
C. Langer
Clinical Lung Cancer
2001
Corpus ID: 23007784
The paclitaxel/carboplatin combination has demonstrated promising activity in metastatic non-small-cell lung cancer (NSCLC…
Expand
Highly Cited
1999
Highly Cited
1999
Cisplatin, gemcitabine, and vinorelbine combination therapy in advanced non-small-cell lung cancer: a phase II randomized study of the Southern Italy Cooperative Oncology Group.
P. Comella
,
G. Frasci
,
+14 authors
G. Comella
Journal of Clinical Oncology
1999
Corpus ID: 31777064
PURPOSE In a previous phase I study cisplatin (CDDP), gemcitabine (GEM), and vinorelbine (VNR) combination therapy was safe and…
Expand
1998
1998
Possible role of glutathione in predicting radiotherapy response of cervix cancer.
Ganesh Krishna R Jadhav
,
Pullara Bhanumathi
,
+5 authors
Johnson Gilbert R Solomon
International Journal of Radiation Oncology…
1998
Corpus ID: 19126041
1997
1997
Results of pneumonectomy for non-small cell lung cancer.
Y. Mizushima
,
H. Noto
,
+4 authors
M. Kobayashi
Acta oncologica
1997
Corpus ID: 23739871
To assess the role of pneumonectomy for lung cancer and the factors affecting the prognosis, 107 patients who had undergone…
Expand
1994
1994
Cathepsin B expression and laminin degradation as factors influencing prognosis of surgically treated patients with lung adenocarcinoma.
Takashi Inoue
,
Teruyoshi Ishida
,
Kenji Sugio
,
K. Sugimachi
Cancer Research
1994
Corpus ID: 20911666
We examined, immunohistochemically, tissues from primary lung adenocarcinomas. In 142 tumors, the mean overall labeling…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE
or Only Accept Required